The FDA has approved Jazz Pharmaceuticals’ sleep disorder drug Xywav, to treat daytime sleepiness in patients with narcolepsy, offering a regime with less sodium than standard therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback